COMPRESSED TABLET COMPOSITION COMPRISING A NSAID
    1.
    发明授权
    COMPRESSED TABLET COMPOSITION COMPRISING A NSAID 有权
    简明含制备的NSAIDs

    公开(公告)号:EP1235558B1

    公开(公告)日:2006-05-03

    申请号:EP00990644.7

    申请日:2000-11-30

    IPC分类号: A61K9/20 A61K31/19

    摘要: A compressed tablet composition comprising:a granular component comprising a plurality of solidified melt granules of a non-steroidal anti-inflammatory drug (NSAID) having a melting point in the range 30-300 DEG C and incorporating a disintegrant uniformly dispersed therein; characterised in that the granules comprise a continuous phase of said non-steroidal anti-inflammatory drug and further characterised in that the tablet composition comprises silicon dioxide present in an amount of 0.05-5.0 % by weight of the composition. Preferably, the composition also contains an extra-granular component comprising the silicon dioxide and a lubricant. Further preferably the NSAID is ibuprofen which has a melting point in the range 75-77 DEG C. Optionally the melting process can be carried out in an extruder. Tablets containing advantageous processing properties and dissolution characteristics are obtained.

    COMPRESSED TABLET COMPOSITION COMPRISING A NSAID
    2.
    发明公开
    COMPRESSED TABLET COMPOSITION COMPRISING A NSAID 有权
    一个行政NSAID含片剂的研制

    公开(公告)号:EP1235558A2

    公开(公告)日:2002-09-04

    申请号:EP00990644.7

    申请日:2000-11-30

    IPC分类号: A61K9/20 A61K31/19

    摘要: A compressed tablet composition comprising:a granular component comprising a plurality of solidified melt granules of a non-steroidal anti-inflammatory drug (NSAID) having a melting point in the range 30-300° C and incorporating a disintegrant uniformly dispersed therein; characterised in that the granules comprise a continuous phase of said non-steroidal anti-inflammatory drug and further characterised in that the tablet composition comprises silicon dioxide present in an amount of 0.05-5.0 % by weight of the composition. Preferably, the composition also contains an extra-granular component comprising the silicon dioxide and a lubricant. Further preferably the NSAID is ibuprofen which has a melting point in the range 75-77° C. Optionally the melting process can be carried out in an extruder. Tablets containing advantageous processing properties and dissolution characteristics are obtained.